Introduction
Prostate cancer is a leading cause of cancer death in most developed countries and an emerging public health problem in developing countries (Jemal et al., 2011) . Globally, prostate cancer is the second most commonly diagnosed cancer and the sixth leading cause of cancer death among men (Jemal et al., 2011) . To date, however, the etiology of this malignancy remains unclear, with age, race, and family history being the only well-established risk factors (Hsing and Devesa, 2001; Leitzmann and Rohrmann, 2012) .
Ecologic and migrant studies have offered substantial evidence that dietary factors may play a role in the etiology of prostate cancer (Rose et al., 1986) . Specifically, populations with high intake of saturated fat and red meats have an increased risk for prostate cancer compared with populations with low intake of these nutrients or food items (Rose et al., 1986; Michaud et al., 2001; Ma and Chapman, 2009) . A marked increase in the risk for this disease has been observed after the immigration of men from East Asia to North America (Whittemore et al., 1995) . Prostate cancer incidence rates have been rapidly increasing in China, Korea, Japan, and Singapore during the last several decades (Zhang et al., 2012) . This upward change has been primarily ascribed to the occurrence of nutrition transition in these countries during the same period of time (Zhang et al., 2012) . Nutrition transition is defined as a gradual change toward the Westernized diet, characterized by high intake of energy, animal fat and meats, and low intake of fiber (Zhang et al., 2012) . Although the aforementioned descriptive epidemiologic studies suggest that dietary habits influence the risk of prostate cancer, case-control and cohort studies have provided mixed results on dietary etiology of this malignancy (Michaud et al., 2001; Zhu et al., 2005) .
Prostate cancer can be either indolent or aggressive. Whereas indolent tumors may remain asymptomatic during the entire lifetime, aggressive tumors can rapidly progress to advanced disease (Brassell et al., 2011) . A growing body of evidence suggests that these two types of prostate cancers have a different etiology (Rose, 1997) . One of the potential reasons for inconsistent results of case-control and cohort studies examining the association between diet and prostate cancer may be that most of these studies had a small number of advanced tumors. Given the clinical importance of advanced prostate cancer, it is crucial to understand which nutrients, foods, or food groups significantly modulate the risk of its occurrence. Therefore, this paper sought to review the current evidence from epidemiologic studies on this topic.
Materials and methods
A PubMed search of published papers was conducted through September 2012 to identify studies eligible for review. A total of 280 papers were found when keywords 'diet' and 'advanced prostate cancer'; 'diet' and 'lethal prostate cancer'; and 'diet' and 'metastatic prostate cancer' were used (Fig. 1) . A paper was eligible for review if it reported separate risk estimates [odds ratio (OR) or relative risk (RR)] for advanced, lethal, or metastatic prostate cancer. The abstracts of all these papers were reviewed to determine whether they met the inclusion criteria. When an abstract did not provide sufficient information for this eligibility evaluation, the full paper was examined instead. Studies were excluded if they were published as a review paper or reported in the form of an abstract only. To ensure the adequacy of published data for review, we only examined the nutrients, foods, or food groups that have been investigated in relation to risk for advanced prostate cancer in at least three independent studies. The nutrients, foods, or food groups that met this criterion are meat and meat products, fat, calcium, dairy products, fruits and vegetables, lycopene, vitamins, fish, and zinc; dietary patterns were also studied in relation to risk for advanced prostate cancer.
The following information was extracted from each of the eligible papers: author(s), publication year, study population, study design, geographical location, sample size, dietary assessment methods, risk estimates [OR or RR and 95% confidence intervals (95% CI)], and confounders controlled for in multiple regression analysis. If more than one paper was published using data collected from the same study, the paper that analyzed most recent data or had the largest (or larger) sample size was included in this review.
Results
The dietary factors reviewed for their associations with the risk of advanced prostate cancer included meat and meat products (Table 1) ; fat (Table 2) ; calcium, vitamin D, and dairy products (Table 3) ; fruits, vegetables, and vitamins (Table 4) ; lycopene and tomato products (Table 5) ; and fish and other dietary factors. Lycopene abounds in tomatoes and tomato products (Giovannucci, 1999) . The results of epidemiologic studies evaluating the effects of tomatoes and tomato products on advanced prostate cancer have been presented in a separate table because a large number of studies have investigated this association. The results shown in all tables are risk estimates (ORs or RRs) comparing the highest with the lowest intake categories of nutrients or foods.
Meat and meat products

Case-control studies
Most case-control studies showed inconsistent associations between meat intake and the risk for advanced prostate cancer, whereas the promoting effect was consistent overall across studies on intake of well-done meats and suspected carcinogens derived from the meats cooked in this manner (Table 1) . In a population-based case-control study, total meat and white meat consumption was not associated with the risk for advanced prostate cancer , but a significantly progressively elevated risk for advanced prostate cancer was observed for higher intake of hamburgers (P = 0.02; John et al., 2011) . In another study, intake of red meat, hamburgers, steak, poultry, sausages, processed meat, and bacon did not alter advanced prostate cancer risk (Joshi et al., 2012) .
A number of suspected mutagens or carcinogens are produced when meats are cooked at high temperature (Sinha et al., 1998; Sugimura et al., 2004; Gu et al., 2010) . Depending on the type of meat and level of doneness, the mutagens detected in cooked meat include: and 2-amino-3,4, 8-trimethylimidazo-[4,5-f] (Sinha et al., 1998; Sugimura et al., 2004; Gu et al., 2010) . One study has demonstrated a marginally significant association between PhIP intake and the risk for advanced prostate cancer [OR (95% CI): 1.2 (0.9, 1.6), for quintile 5 vs. quintile 1] (Joshi et al., 2012) . In addition, intake of red meat [OR (95% CI): 1.4 (1.0, 1.9), for quintile 5 vs. quintile 1, P = 0.026] and hamburger [OR (95% CI): 1.7 (1.3, 2.2), for quartile 4 vs. quartile 1, P = < 0.001] cooked at high temperature, well-done red meat [OR (95% CI): 1.4 (1.1, 1.8), for quartile 4 vs. quartile 1, P = 0.013], and pan-fried red meat [OR (95% CI): 1.3 (1.0, 1.8), for quartile 4 vs. quartile 1, P = 0.035] were found to increase the risk of advanced prostate cancer (Joshi et al., 2012) . These results were confirmed by a study in which an increased risk was found to be associated with high intake of grilled beef, well-done beef, and well-done hamburger (Punnen et al., 2011) . In addition, intake of MelQx [OR (95% CI): 1.69 (1.08, 2.64), for quartile 4 vs. quartile 1, P = 0.02] and DiMelQX [OR (95% CI): 1.53 (1.00, 2.35), for quartile 4 vs. quartile 1, P = 0.005] were associated with an elevated risk for aggressive prostate cancer (clinical stage III/IV tumors or Gleason score Z 7; Punnen et al., 2011) . However, Amin et al. (2008) found no association between intake of red meat, ham and sausages (analyzed as one group), and chicken and the risk for aggressive prostate cancer.
Cohort studies
Overall, cohort studies conducted to date reveal a modest, inconsistent association between intake of meat and meat products and the risk of advanced prostate cancer (Table 1) . Total meat consumption was weakly associated with a significantly reduced risk for advanced prostate cancer in one study (Koutros et al., 2008) . An inverse but insignificant association was detected between intake of total unprocessed red meat and the risk of lethal prostate cancer (Richman et al., 2011) .
Although the results on the associations of red or white meat consumption with advanced prostate cancer risk were conflicting, most studies suggested that high intake of meats cooked at high temperature significantly increased risk (Schuurman et al., 1999; Cross et al., 2005; Koutros et al., 2008; John et al., 2011; Sander et al., 2011; Wright et al., 2011) . Intake of red meat, processed meat, heme iron, nitrite/nitrate (derived from meat, grilled or barbecued meat), and BaP conferred an elevated risk for advanced prostate cancer in one study (Sinha et al., 2009 ). However, dietary iron was not associated with the risk of advanced prostate cancer in another study (Choi et al., 2008) . It has also been reported that intake of well-done meat was associated with an approximately two-fold increase in the risk for advanced disease in a dose-response manner [RR (95% CI): 1.97 (1.26, 3.08), for tertile 3 vs. tertile 1, P = 0.004] (Koutros et al., 2008) . Increased risk associated with consumption of very well-done or strongly browned meat was not statistically significant in other studies (Cross et al., 2005; Sander et al., 2011) . Hamburger intake was not associated with risk of advanced prostate cancer (Koutros et al., 2008) . In addition, intake of PhIP, MeIQx, and DiMeIQx did not significantly influence the risk for advanced prostate cancer in a European study (Sander et al., 2011) .
The effect of total protein intake was examined but no significant association was found with the risk of advanced prostate cancer, and null results were also obtained for the association between intake of animal, dairy, and plant proteins and the risk for advanced prostate cancer (Allen et al., 2008) . Liver intake was significantly associated with a reduced risk for advanced prostate cancer [RR (95% CI): 0.79 (0.63, 0.99), for quartile 4 vs. quartile 1] in a Dutch study (Schuurman et al., 1999) .
Fat
Case-control studies
Case-control studies have consistently revealed that total fat intake and particularly saturated fat intake were significantly associated with an increased risk for advanced prostate cancer (Slattery et al., 1990; Whittemore et al., 1995; Bairati et al., 1998; De Stefani et al., 2000;  Table 2 ). Dietary intake of monounsaturated fat (Bairati et al., 1998; De Stefani et al., 2000) , polyunsaturated fat (Bairati et al., 1998; Agalliu et al., 2011) , linoleic acid, and linolenic acid (Bairati et al., 1998; De Stefani et al., 2000) was generally not associated with advanced prostate cancer risk. When the type and source of linolenic acid were considered, a-linolenic acid and linolenic acid from animal et al., 1998) .
Cohort studies
To our knowledge, only one cohort study has examined fat intake in relation to the risk for advanced prostate cancer. Phytanic acid is a saturated fatty acid present predominantly in red meat and dairy products. Higher phytanic acid intake was associated with an elevated risk for advanced prostate cancer [RR (95% CI): 1.38 (1.02, 1.89), for quartile 4 vs. quartile 1] (Wright et al., 2011) .
Calcium, vitamin D, and dairy products
Case-control studies Dairy products are rich sources of calcium and vitamin D (Rowland et al., 2011) . At the time this review was prepared, only one case-control study had investigated the association between calcium intake and advanced prostate cancer risk (Table 3) . High calcium intake was (Rowland et al., 2011) . Similar results were obtained when total intake of calcium from both diet and supplements was used in the analysis (Rowland et al., 2011) . No association was found between intake of dairy products and the risk of advanced prostate cancer (Amin et al., 2008) .
Cohort studies
Although most cohort studies suggested that high calcium intake increased the risk for advanced prostate cancer, the effects of milk and other dairy products on aggressive prostate tumors were inconsistent across those studies (Table 3) . Schuurman et al. (1999) reported no association between intake of milk and milk products and the risk of advanced prostate cancer. However, a significant positive association with calcium intake was observed in another study [RR (95% CI): 1.62 (1.08, 2.43), for quartile 4 vs. quartile] (Wright et al., 2011) . This finding was confirmed by a large cohort study . In the latter study, high calcium consumption significantly increased the risk for advanced prostate cancer [RR (95% CI): 2.97 (1.61, 5.50), for Z 2000 vs. <500 mg/day intake, P = 0.002] . In a prospective cohort study in which 1426 cases of advanced prostate cancer were accrued during 6 years of follow-up, a positive but insignificant association was observed between total calcium intake and advanced prostate cancer risk (Park et al., 2007) . Two other studies did not reveal the positive association of total calcium and dietary and supplemental calcium with the risk for advanced prostate cancer (Ahn et al., 2007; Allen et al., 2008) .
The association of other dairy products with the risk for advanced prostate cancer was also evaluated in many studies. Skimmed milk was associated with an elevated risk for advanced prostate cancer [RR (95% CI): 1.23 (0.99, 1.64), for >2000 vs. <500 mg/day intake, P = 0.01] (Park et al., 2007) . However, intake of low-fat milk did not alter the risk for advanced prostate cancer (Schuurman et al., 1999) , or even reduced the risk (Wright et al., 2011) . In a Dutch population, significant positive association was detected between intake of butter and cheese and the risk for advanced prostate cancer (Wright et al., 2011) . In the Prostate, Lung, Colorectal, and Ovarian Cancer Prevention Trial, intake of total dairy, low-fat dairy, and high-fat dairy products did not influence the risk for aggressive prostate cancer (Ahn et al., 2007) . Further, intake of calcium from dietary and supplemental sources did not alter the risk of aggressive prostate cancer (Ahn et al., 2007) . In only one study, the association between vitamin D and advanced prostate cancer risk was examined, with null results reported (Giovannucci and Clinton, 1998) .
Fruits, vegetables, and vitamins
Case-control studies A few case-control studies have reported an overall inverse association between intake of fruits and vegetables and the risk for advanced prostate cancer (Table 4) . Kolonel et al. (2000) have reported that intake of all vegetables was associated with a 33% reduced risk for advanced prostate cancer. This protective effect was confined to yellow-green vegetables, cruciferous vegetables, and carrots (Kolonel et al., 2000) . Intake of fruits did not modulate the risk for advanced prostate cancer (Kolonel et al., 2000) . When aggressive prostate cancer was considered, only leafy vegetables [OR (95% CI): 0.66 (0.46, 0.96), for quartile 4 vs. quartile 1, P = 0.02] were found to be protective . Intake of all vegetables, carotenoid-rich vegetables, all fruits (excluding juice), and vitamin C were marginally significantly associated with a reduced risk for aggressive prostate cancer (P = 0.04 for all vegetables; Hardin et al., 2011) . However, the aforementioned potential benefits conferred by vegetable consumption were not observed in another case-control study (Amin et al., 2008) .
Cohort studies
The results from cohort studies examining the association between intake of fruits and vegetables and the risk of advanced prostate cancer were largely inconsistent (Table 4 ). In a cohort study, fruit intake was inversely associated with the risk for advanced prostate cancer [RR (95%): 0.63 (0.43, 0.93), for >5 vs. r 1 servings/day]. However, this inverse association was primarily accounted for by fructose intake [RR (95%) CI: 0.51 (0.33, 0.80), for >70 vs. r 40 g/day, P = 0.007] . Takachi et al. (2010) did not find any association between fruit intake and the risk for advanced prostate cancer. Most cohort studies did not reveal that intake of total vegetables, green leafy vegetables, yellow vegetables, cruciferous vegetables, and fruits protected against advanced prostate cancer (Giovannucci et al., 2003; Takachi et al., 2010; Agalliu et al., 2011) .
Micronutrients abound in fresh vegetables and fruits. Several studies have examined the association between micronutrients and advanced prostate cancer risk. It was reported that higher intake of menaquinones ( phylloquinone (vitamin K 1 ), and folate in some other studies (Stevens et al., 2006; Weinstein et al., 2007; Nimptsch et al., 2008; Agalliu et al., 2011) . The influence of vitamin supplement use on prostate cancer risk has also been evaluated . In the NIH-AARP Diet and Health Study, men who reported an excessive use of multivitamins showed a significantly increased risk for advanced prostate cancer [RR (95%):
1.32 (1.04, 1.67), for quartile 4 vs. quartile 1] . However, some individual micronutrients (vitamin E, selenium, and folate) were not associated with the risk for advanced prostate cancer in the same study . Similar null results were found for nutrients involved in one-carbon metabolism (folate, vitamin B 2 , vitamin B 6 , vitamin B 12 , and methionine) in another cohort study (Kasperzyk et al., 2009) . 
Lycopene and tomato products
There is a growing body of evidence that lycopene has a beneficial effect on prostate cancer (Dahan et al., 2008; Haseen et al., 2009; Tan et al., 2010) . Lycopene may suppress prostate carcinogenesis through decreasing lipid oxidation, enhancing antioxidant capacities, and inhibiting cell proliferation (Tan et al., 2010; Wei and Giovannucci, 2012) . The association between lycopene intake and advanced prostate cancer has been evaluated in several studies (Table 5) . Giovannucci et al. (2002) reported an inverse association between tomato sauce intake and advanced prostate cancer risk. In a European study, plasma concentrations of lycopene were associated with a 60% reduced risk for advanced prostate cancer [RR 95% CI: 0.40 (0.19, 0.88), for quintile 5 vs. quintile 1] (Key et al., 2007) . It should be pointed out that a protective effect on advanced prostate cancer was not detected in some other studies on the intake of lycopene (Kirsh et al., 2006; Agalliu et al., 2011) , tomatoes and tomato products (Takachi et al., 2010) , and other tomatobased food products (pizza, lasagna, and spaghetti; Kirsh et al., 2006) .
Other dietary factors
Other dietary factors in relation to advanced prostate cancer are briefly summarized below because of the relative scarcity of data available from epidemiologic studies. 
Fish
Three cohort studies, conducted in the Netherlands (Schuurman et al., 1999) , the USA (Augustsson et al., 2003) , and Finland (Wright et al., 2011) , showed that fish consumption did not influence the risk for advanced prostate cancer. However, a significantly reduced risk for metastatic prostate cancer associated with fish consumption was observed in a US cohort [RR (95% CI): 0.56 (0.37, 0.86), for quartile 4 vs. quartile 1] (Augustsson et al., 2003) .
Tea
A number of animal studies have shown that green tea extracts (including polyphenols and catechins) inhibit the growth of prostate tumor (Siddiqui et al., 2006; Henning et al., 2011) . This anticarcinogenic effect has been extensively reviewed in a meta-analysis (Zheng et al., 2011) . To our knowledge, only one epidemiologic study has investigated the effect of tea consumption on prostate cancer risk (Kurahashi et al., 2008) . In that cohort study among Japanese men, green tea consumption was associated with a 48% reduced risk for advanced prostate cancer after adjustment for confounders [RR (95% CI): 0.52 (0.28-0.96) for quintile 5 vs. quintile 1] (Kurahashi et al., 2008) . In a randomized chemoprevention trial including 60 volunteers with high-grade prostate intraepithelial neoplasia (precursors of prostate cancer), men who received 600 mg/day green tea catechins showed a significantly lower risk for prostate cancer than those who received placebo after 1-year follow-up (incidence: 3.3% in intervention vs. 30% in placebo, P < 0.01; Bettuzzi et al., 2006) .
Zinc
In a case-control study conducted by Gallus et al. (2007) , zinc intake was not associated with an altered risk for advanced prostate cancer, but a potentially reduced risk was observed in a cohort study [RR (95% CI): 0.67 (0.41, 1.10), for quartile 4 vs. quartile 1] (Epstein et al., 2011) . This insignificant benefit was also observed for intake of zinc from supplements for Stefani et al., 2010) ; however, an American study shows contradictory results (Wu et al., 2006) .
Discussion
Overall, epidemiologic evidence suggests that the habitual consumption of a diet high in saturated fat, welldone meats, and calcium conferred an increased risk for advanced prostate cancer. The effects of other nutrients and foods on the development of advanced prostate cancer were largely inconsistent across epidemiologic studies.
A number of epidemiologic studies have shown that total meat intake and white meat intake are not associated with the risk for advanced prostate cancer (Alexander et al., 2010) . However, methods for cooking meats should be considered when meat consumption is evaluated for its effect on prostate carcinogenesis. Most, although not all, epidemiologic studies have consistently revealed that intake of well-done meats and mutagens derived from meats cooked at high temperature (e.g. grilled, fried, and barbecued meats) is associated with a significantly elevated risk for advanced prostate cancer in a doseresponse manner (P r 0.01 for well-done meats for most studies; Koutros et al., 2008; Sinha et al., 2009; Punnen et al., 2011) . The ORs or RRs for the highest versus lowest categories of intake of well-done meats ranged from 1.28 to 2.16 (Cross et al., 2005; Koutros et al., 2008; Sinha et al., 2009; Punnen et al., 2011; Joshi et al., 2012) . The potential role of well-done meats in prostate cancer etiology is biologically plausible because prostate tumors have been induced in rats fed with a meat-derived mutagen (PhIP; Shirai et al., 1997) . Further, PhIP-DNA adducts that may cause DNA mutations and initiate carcinogenesis were detected in all lobes of the prostate of rats receiving PhIP in the same study (Shirai et al., 1997) .
As mentioned previously, ecologic and migrant studies strongly suggest that intake of fat, especially animal fat (primarily saturated fat), was associated with an increased risk for prostate cancer (Rose et al., 1986; Whittemore et al., 1995) . This observation has gained further support from increasing trends in prostate cancer incidence in East Asia over last few decades, probably as a consequence of nutrition transition toward the Western diet (Zhang et al., 2012) . However, the results from analytical epidemiologic studies on the effect of fat and types of fat on prostate cancer risk were mixed. Most case-control studies have shown a significant, positive association between total fat intake, especially saturated fat, and the risk for advanced prostate cancer, with risk estimates (ORs) ranging from 1.4 to 8.7 (Whittemore et al., 1995; Bairati et al., 1998; De Stefani et al., 2000) . A number of animal studies have suggested that fat is implicated in prostate carcinogenesis by promoting oxidative stress and inflammation in the prostate gland (Hill, 1987; Vykhovanets et al., 2011) .
To date, one case-control study has demonstrated that dietary intake of calcium was monotonically associated with an increased risk for advanced prostate cancer (P = 0.001; Rowland et al., 2011) . Similar but less consistent results were obtained from cohort studies. Vitamin D was not associated with an elevated risk for advanced prostate cancer (Giovannucci and Clinton, 1998) . Vitamin D enhances the absorption of calcium in the gut. Experimental studies have shown that vitamin D promotes the differentiation and suppresses the proliferation of prostate cells (Samuel and Sitrin, 2008) . It has been suggested that high calcium intake increases the risk for prostate cancer through reducing circulating levels of 1,25-dihydroxyvitamin D, the most active form of vitamin D (Williams et al., 2012) .
Most case-control studies have shown a significant inverse association between intake of vegetables (yellowgreen, cruciferous, carrots, and legumes) and the risk for advanced prostate cancer, with risk estimates (ORs) ranging from 0.36 to 0.96 (Kolonel et al., 2000; Hardin et al., 2011) . However, no association was found between intake of vegetables and the risk for advanced prostate cancer in most cohort studies (Stevens et al., 2006; Takachi et al., 2010; Agalliu et al., 2011) . Similarly, overall, fruit intake was not associated with the risk for advanced prostate cancer in both case-control (Kolonel et al., 2000; Amin et al., 2008; Hardin et al., 2011) and cohort studies (Takachi et al., 2010) . Excessive use of multivitamins increases the risk for advanced prostate cancer . Vitamin E naturally occurs in eight chemical forms, which include tocopherols and tocotrienols (Jiang et al., 2001) ; intake of a-tocopherol, g-tocopherol, and d-tocopherol has been significantly associated with a reduced risk for advanced prostate cancer, with reported risk estimates (RRs) ranging from 0.36 to 0.96 Wright et al., 2007) . Vegetables and fruits contain a variety of chemical compounds including vitamin C, carotenoids, flavonoids, phenols, and fiber. These molecules possess antioxidant properties, bind and dilute carcinogens, or alter hormone metabolism (McDermott, 2000) , which are biochemical mechanisms for the protective effect of vegetables and fruits on prostate cancer.
Lycopene is derived largely from tomatoes and tomatobased products (Dahan et al., 2008) . As experimental studies have provided ample evidence supporting the fact that lycopene has anticarcinogenic properties, which have been mentioned previously, a number of epidemiologic studies have investigated its effect on total prostate cancer (Etminan et al., 2004; Key et al., 2011) . A metaanalysis showed a modest inverse association between lycopene intake and the risk for total prostate cancer (Etminan et al., 2004) . Among a few studies that reported risk estimates for advanced prostate cancer, a significantly reduced risk was observed for men who exhibited high plasma concentrations of lycopene in an European cohort study (Key et al., 2007) . However, this protective effect was not detected in other cohort studies on the basis of analysis of dietary intake of lycopene (Kirsh et al., 2006; Agalliu et al., 2011) . It has been reported that lycopene from raw and cooked tomatoes has different intestinal bioavailability (Gartner et al., 1997) , which may offer a partial explanation for the null effect of dietary lycopene on advanced prostate cancer.
The results obtained from epidemiologic studies on dietary patterns in relation to disease risk are more directly applicable to dietary recommendations than those from studies on individual nutrients because people can manipulate nutrient intake by their choice of foods. Two case-control studies have shown that maintaining a Western diet pattern was significantly associated with an over two-fold elevated risk for advanced prostate cancer in a dose-response manner (P < 0.001; Ambrosini et al., 2008; De Stefani et al., 2010) . Similar results were not observed from a cohort study (Wu et al., 2006) . In addition, other dietary patterns (e.g. a prudent dietary pattern) were not found to influence the risk for advanced prostate cancer (Wu et al., 2006; De Stefani et al., 2010) . Collectively, more epidemiologic studies are encouraged to evaluate the effect of various dietary patterns on the occurrence of total and particularly aggressive prostate cancer because of the importance and relevance of research in this area for cancer etiology, prevention, and control.
Several factors might have contributed to the observed inconsistent results for some nutrients and foods in relation to advanced prostate cancer. To date, most studies on this topic have only examined total prostate cancer. In the studies that reported separate results for advanced tumors, the number of advanced prostate cancer cases was generally small, which offers inadequate statistical power to detect modest effects. In addition, scarce data are available on the effect of diet on the risk for aggressive and metastatic prostate cancer. Measured and unmeasured confounding factors should be considered in the interpretation of results obtained from any epidemiologic study. Although age, race, and family history were treated as confounders in most studies, adjustment for other potential confounding factors was different among reviewed studies. Finally, the Food Frequency Questionnaire has been used in the majority of nutritional epidemiologic studies over last two decades. A number of validation studies have shown that under-reporting of fat and meat and over-reporting of vegetable and fruit intake are common among these studies (Macdiarmid and Blundell, 1998) . These dietary measurement errors could result in misclassification of individuals with regard to their dietary intake of nutrients and foods and consequently the attenuation of true associations of dietary factors with the risk for advanced prostate cancer (Bingham et al., 2003) . Recall bias inherent in the Food Frequency Questionnaire could be overcome by measuring biochemical indicators of nutrients in various biological specimens (e.g. blood, urine, and tissue). However, these nutritional biomarkers were not determined in most epidemiologic studies.
Conclusion
Overall, epidemiologic studies conducted to date suggest that high intake of saturated fat, meats cooked at high temperature, and calcium is associated with an increased risk for advanced prostate cancer. It should be noted that these results were largely based on a relatively small number of advanced prostate tumors in most epidemiologic studies reviewed. More adequately powered epidemiologic studies (especially prospective cohort studies) that measure both dietary intake of nutrients and their biomarkers are warranted to further elucidate the role of diet in the etiology of advanced prostate cancer. As dietary factors are modifiable, identifying nutrients or food groups that modulate the risk for advanced prostate cancer can offer effective and practical strategies for its primary prevention.
